Predictors of the Development of Associated Clinical Conditions in Working-Age Patients With Cardiovascular Risk

N A Koziolova1, A I Chernyavina1, E A Polyanskaya1

  • 1Vagner Perm State Medical University.

Kardiologiia
|February 7, 2024
PubMed

Insights

Predictors for associated clinical conditions (ACC) in working-age patients with cardiovascular risk factors (CVRFs) include smoking, type 2 diabetes, and chronic kidney disease. Genetic factors like AGT, APOE, and PPARα gene polymorphisms also significantly increase ACC risk, even with high treatment compliance.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • Cardiovascular risk factors (CVRFs) are prevalent in working-age populations.
  • High compliance with treatment and healthy lifestyle (HLS) are crucial for managing CVRFs.
  • Identifying predictors for associated clinical conditions (ACC) is vital for proactive patient management.

Purpose of the Study:

  • To determine predictors for the development of ACC in working-age patients with CVRFs.
  • To investigate these predictors under conditions of high treatment compliance and HLS.

Main Methods:

  • A cohort of 364 patients with CVRFs but no target organ damage or prior ACC was studied.
  • Follow-up lasted 6.45±0.42 years, with 350 patients completing the study.
  • Statistical analyses, including regression logistic and correlation, identified significant predictors.

Main Results:

  • Smoking, type 2 diabetes mellitus (DM), and chronic kidney disease (CKD) significantly increased ACC risk.
  • History of COVID-19 pneumonia, left ventricular hypertrophy (LVH), and increased indexed left atrial volume (ILAV) were also key predictors.
  • Arterial stiffness indicators (CAVI, PWVcf, R-AI) and specific gene polymorphisms (AGT, APOE, PPARα) were strongly associated with ACC development.

Conclusions:

  • ACC development in compliant patients is linked to modifiable factors like smoking, DM, CKD, and COVID-19 history.
  • Structural heart changes (LVH, ILAV) and arterial stiffness are significant indicators.
  • Genetic predispositions, particularly homozygosity for minor alleles in AGT, APOE, and PPARα genes, substantially elevate ACC risk.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.2K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
59
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92